Merck
  • Home
  • Search Results
  • Covalent bridging of surface functionalized Fe3O4 and YPO4:Eu nanostructures for simultaneous imaging and therapy.

Covalent bridging of surface functionalized Fe3O4 and YPO4:Eu nanostructures for simultaneous imaging and therapy.

Dalton transactions (Cambridge, England : 2003) (2015-07-29)
K C Barick, Anusha Sharma, Neena G Shetake, R S Ningthoujam, R K Vatsa, P D Babu, B N Pandey, P A Hassan
ABSTRACT

Magnetic luminescent hybrid nanostructures (MLHN) have received a great deal of attention due to their potential biomedical applications such as thermal therapy, magnetic resonance imaging, drug delivery and intracellular imaging. We report the development of bifunctional Fe3O4 decorated YPO4:Eu hybrid nanostructures by covalent bridging of carboxyl PEGylated Fe3O4 and amine functionalized YPO4:Eu particles. The surface functionalization of individual nanoparticulates as well as their successful conjugation was evident from Fourier transform infrared (FTIR) spectroscopy, dynamic light scattering (DLS), zeta-potential and transmission electron microscopy (TEM) studies. X-ray diffraction (XRD) analysis reveals the formation of highly crystalline hybrid nanostructures. TEM micrographs clearly show the binding/anchoring of 10 nm Fe3O4 nanoparticles onto the surface of 100-150 nm rice grain shaped YPO4:Eu nanostructures. These MLHN show good colloidal stability, magnetic field responsivity and self-heating capacity under an external AC magnetic field. The induction heating studies confirmed localized heating of MLHN under an AC magnetic field with a high specific absorption rate. Photoluminescence spectroscopy and fluorescence microscopy results show optical imaging capability of MLHN. Furthermore, successful internalization of these MLHN in the cells and their cellular imaging ability are confirmed from confocal microscopy imaging. Specifically, the hybrid nanostructure provides an excellent platform to integrate luminescent and magnetic materials into one single entity that can be used as a potential tool for hyperthermia treatment of cancer and cellular imaging.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Diglycolic acid, 98%
Sigma-Aldrich
Yttrium, ingot, 99.9% trace rare earth metals basis
Sigma-Aldrich
Yttrium, powder, −40 mesh, 99.5% trace rare earth metals basis
Sigma-Aldrich
Yttrium, chips, 99.9% trace rare earth metals basis
Sigma-Aldrich
Tetraethyl orthosilicate, ≥99.0% (GC)
Sigma-Aldrich
Thiazolyl Blue Tetrazolium Bromide, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥97.5% (HPLC)
Sigma-Aldrich
Thiazolyl Blue Tetrazolium Bromide, 98%
Sigma-Aldrich
Nitric-14N acid solution, ~10 N in H2O, 99.99 atom % 14N
Sigma-Aldrich
Ammonia-14N, 99.99 atom % 14N
Sigma-Aldrich
Tetraethyl orthosilicate, packaged for use in deposition systems
Yttrium, foil, 50x50mm, thickness 0.15mm, as rolled, 99%
Yttrium, wire reel, 0.05m, diameter 1.0mm, square section, 99.9%
Yttrium, wire reel, 0.1m, diameter 1.0mm, 99.9%
Yttrium, wire reel, 0.2m, diameter 0.5mm, 99.9%
Yttrium, rod, 100mm, diameter 6.35mm, cast, 99%
Sigma-Aldrich
Yttrium sputtering target, diam. × thickness 2.00 in. × 0.25 in., 99.9% trace metals basis
Yttrium, foil, 25x25mm, thickness 0.15mm, as rolled, 99%
Yttrium, foil, 50x50mm, thickness 0.125mm, as rolled, 99%
Yttrium, foil, 25mm disks, thickness 0.50mm, as rolled, 99%
Yttrium, foil, not light tested, 25x25mm, thickness 0.005mm, as rolled, 99%
Yttrium, foil, not light tested, 100x100mm, thickness 0.025mm, as rolled, 99%
Yttrium, foil, not light tested, 25x25mm, thickness 0.025mm, as rolled, 99%
Yttrium, foil, not light tested, 50x50mm, thickness 0.025mm, as rolled, 99%
Yttrium, foil, 25x25mm, thickness 0.125mm, as rolled, 99%
Yttrium, rod, 100mm, diameter 12.5mm, cast, 99%
Yttrium, wire reel, 0.1m, diameter 0.5mm, 99.9%
Yttrium, wire reel, 0.05m, diameter 1.0mm, 99.9%
Yttrium, wire reel, 0.2m, diameter 1.0mm, 99.9%
Yttrium, wire reel, 0.05m, diameter 0.5mm, 99.9%
Yttrium, rod, 50mm, diameter 12.5mm, cast, 99%